Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 31, 2022
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
Yuan Zhi Maintained (ATNM) at Strong Buy with Increased Target to $18 on, Oct 31st, 2022
Yuan Zhi of B. Riley Securities, Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy with Increased Target from $16 to $18 on, Oct 31st, 2022.
Yuan has made no other calls on ATNM in the last 4 months.
There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Yuan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yuan
- Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $20 on, Thursday, September 8th, 2022
